Australia Dengue Treatment Market to 2032
Overview
The Australia Dengue Treatment Market is expected to reach a 59.18 USD Million by 2032 and is projected to grow at a CAGR of 12.41% from 2025 to 2032.
Revenue, 2024 (USD Million)
25.77
Forecast, 2032 (USD Million)
59.18
CAGR, 2024 - 2032
12.41%
Report Coverage
Australia
Australia Dengue Treatment Market 2018-2032 USD Million
Australia Dengue Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 25.77 USD Million
- Projected Market Size (2032): 59.18 USD Million
- CAGR (2025-2032): 12.41%
Key Findings of Australia Dengue Treatment Market
- The Australia Dengue Treatment Market was valued at 25.77 USD Million in 2024.
- The Australia Dengue Treatment Market is likely to grow at a CAGR of 12.41% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription in Mode of Purchase Segment accounted for the largest share of the market with a revenue of 21.66 USD Million
- The fastest growing segment Home Healthcare in End User Segment grew Fastest with a CAGR of 13.37% during the forecast period from 2024 to 2032.
Australia Dengue Treatment Market Scope
Australia Dengue Treatment Market Segmentation & Scope
Strains
- DENV-2
- Others
- DENV-4
- DENV-1
- DENV-3
Route of Administration
- Oral
- Parenteral
Severity
- Severe Dengue
- Mild to Moderate Dengue
Type
- Acetaminophen
- Vaccines
Mode of Purchase
- Over-The-Counter (OTC)
- Prescription
Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
End User
- Others
- Home Healthcare
- Specialty Clinics
- Hospital
Age
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Australia Dengue Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 25.77 USD Million |
| Market Value in 2032 | 59.18 USD Million |
| CAGR (2025-2032) | 12.41% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Strains,Route of Administration,Severity,Type,Mode of Purchase,Distribution Channel,End User,Age,Gender |
Regional Insights:
-
Leading Market (2024-2032): Australia, leading in terms of revenue 25.77 USD Million in 2024
- Key Country: Australia, leading in terms of revenue with value of 25.77 USD Million in 2024.
Segments and Scope
-
Australia Dengue Treatment Market to 2032, By Strains
- DENV-2 is the largest segment in Australia Dengue Treatment Market to 2032 with a revenue of 9.75 USD Million in the year 2024.
- DENV-1 is the Fastest growing segment in Australia Dengue Treatment Market to 2032 with a Growth rate of 12.20 % in forecast period 2025-2032.
-
Australia Dengue Treatment Market to 2032, By Route of Administration
- Parenteral is the largest segment in Australia Dengue Treatment Market to 2032 with a revenue of 21.56 USD Million in the year 2024.
- Parenteral is the Fastest growing segment in Australia Dengue Treatment Market to 2032 with a Growth rate of 12.52 % in forecast period 2025-2032.
-
Australia Dengue Treatment Market to 2032, By Severity
- Mild to Moderate Dengue is the largest segment in Australia Dengue Treatment Market to 2032 with a revenue of 16.10 USD Million in the year 2024.
- Mild to Moderate Dengue is the Fastest growing segment in Australia Dengue Treatment Market to 2032 with a Growth rate of 12.73 % in forecast period 2025-2032.
-
Australia Dengue Treatment Market to 2032, By Type
- Vaccines is the largest segment in Australia Dengue Treatment Market to 2032 with a revenue of 16.26 USD Million in the year 2024.
- Vaccines is the Fastest growing segment in Australia Dengue Treatment Market to 2032 with a Growth rate of 13.36 % in forecast period 2025-2032.
-
Australia Dengue Treatment Market to 2032, By Mode of Purchase
- Prescription is the largest segment in Australia Dengue Treatment Market to 2032 with a revenue of 21.66 USD Million in the year 2024.
- Prescription is the Fastest growing segment in Australia Dengue Treatment Market to 2032 with a Growth rate of 12.52 % in forecast period 2025-2032.
-
Australia Dengue Treatment Market to 2032, By Distribution Channel
- Retail Pharmacies is the largest segment in Australia Dengue Treatment Market to 2032 with a revenue of 14.09 USD Million in the year 2024.
- Online Pharmacies is the Fastest growing segment in Australia Dengue Treatment Market to 2032 with a Growth rate of 12.53 % in forecast period 2025-2032.
-
Australia Dengue Treatment Market to 2032, By End User
- Hospital is the largest segment in Australia Dengue Treatment Market to 2032 with a revenue of 15.37 USD Million in the year 2024.
- Home Healthcare is the Fastest growing segment in Australia Dengue Treatment Market to 2032 with a Growth rate of 12.65 % in forecast period 2025-2032.
-
Australia Dengue Treatment Market to 2032, By Age
- Adult is the largest segment in Australia Dengue Treatment Market to 2032 with a revenue of 15.41 USD Million in the year 2024.
- Pediatric is the Fastest growing segment in Australia Dengue Treatment Market to 2032 with a Growth rate of 12.09 % in forecast period 2025-2032.
-
Australia Dengue Treatment Market to 2032, By Gender
- Male is the largest segment in Australia Dengue Treatment Market to 2032 with a revenue of 18.75 USD Million in the year 2024.
- Male is the Fastest growing segment in Australia Dengue Treatment Market to 2032 with a Growth rate of 12.63 % in forecast period 2025-2032.
Australia Dengue Treatment Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Takeda Pharmaceutical Company Limited | |||
| Sanofi | |||
| GSK plc. | |||
Australia Dengue Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
Australia Dengue Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Australia Dengue Treatment Market is segmented based on Segmentation Strains,Route of Administration,Severity,Type,Mode of Purchase,Distribution Channel,End User,Age,Gender.
Australia Dengue Treatment Market was valued at USD 25.77(Revenue in USD Million) in 2022.
Australia Dengue Treatment Market is projected to grow at a CAGR of 12.41% during the forecast period of 2024 to 2032.
The Prescription segment is expected to dominate the Australia Dengue Treatment Market, holding a largest market share of 21.66 USD Million in 2024
Australia Dengue Treatment Market Scope
Australia Dengue Treatment Market Segmentation & Scope
Strains
- DENV-2
- Others
- DENV-4
- DENV-1
- DENV-3
Route of Administration
- Oral
- Parenteral
Severity
- Severe Dengue
- Mild to Moderate Dengue
Type
- Acetaminophen
- Vaccines
Mode of Purchase
- Over-The-Counter (OTC)
- Prescription
Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
End User
- Others
- Home Healthcare
- Specialty Clinics
- Hospital
Age
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Frequently Asked Questions
The Australia Dengue Treatment Market is segmented based on Segmentation Strains,Route of Administration,Severity,Type,Mode of Purchase,Distribution Channel,End User,Age,Gender.
Australia Dengue Treatment Market was valued at USD 25.77(Revenue in USD Million) in 2022.
Australia Dengue Treatment Market is projected to grow at a CAGR of 12.41% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Dengue Treatment Market for final year is USD 59.18 (USD Million).
Australia Dengue Treatment Market Company Profiling
Frequently Asked Questions
The Australia Dengue Treatment Market is segmented based on Segmentation Strains,Route of Administration,Severity,Type,Mode of Purchase,Distribution Channel,End User,Age,Gender.
Australia Dengue Treatment Market was valued at USD 25.77(Revenue in USD Million) in 2022.
Australia Dengue Treatment Market is projected to grow at a CAGR of 12.41% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Dengue Treatment Market for final year is USD 59.18 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.